Response of the Urothelial Carcinoma Cell Lines to Cisplatin

Number of the records: 1

Title	Response of the Urothelial Carcinoma Cell Lines to Cisplatin
Author	Holíčková Andrea SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV
Co-authors	Roška Jan SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV
	Órásová Eveline SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV
	Bruderová V. SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV
	Palacka Patrik
	Jurkovičová Dana 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ^ORCID
	Chovanec Miroslav 1969- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV

Source document	International Journal of Molecular Sciences. Vol. 23, no. 20 (2022), art. no. 12488
Language	eng - English
Country	CH - Switzerland
Note	open access
URL	URL link
Document kind	rozpis článkov z periodík (rzb)
Citations	STEELE, T.M. - TSAMOURI, M.M. - SIDDIQUI, S. - LUCCHESI, C.A. - VASILATIS, D. - MOOSO, B.A. - DURBIN-JOHNSON, B.P. - MA, A.H. - HEJAZI, N. - PARIKH, M. - MUDRYJ, M. - PAN, C.X. - GHOSH, P.M. Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. In SCIENTIFIC REPORTS. ISSN 2045-2322, JUN 14 2023, vol. 13, no. 1. Dostupné na: https://doi.org/10.1038/s41598-023-36774-1.
Category	ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2022
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.3390/ijms232012488

article

	File name	Access	Size	Downloaded	Type	License
	Response of the Urothelial Carcinoma Cell Lines to Cisplatin.pdf	available	1.3 MB	4	Publisher's version

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2022	2021	6.208	Q1	1.176	Q1

Number of the records: 1